Search results
ENDRA meets with FDA on liver device clinical trial design By Investing.com
Investing.com· 12 hours agoFood and Drug Administration (FDA) regarding its TAEUS liver device. The meeting, which took place...
Mizuho raises Sarepta Therapeutics stock target on FDA hopes By Investing.com
Investing.com· 4 days agoThis adjustment comes after a discussion with a former FDA regulatory clinical expert, which...
Boston Scientific (BSX) mCRM System Study Outcome Favorable
Zacks via Yahoo Finance· 15 hours agoThe company anticipates FDA approval of the mCRM System in 2025. Study Details The trial assessed...
In-depth coverage of a hidden danger in baby food: Toxic Inaction leaves kids at risk
WJLA· 4 days agoIt was a disturbing case study and something the Spotlight team has been reporting on for years -...
Amgen shares hold as FDA approves Imdelltra ahead of schedule By Investing.com
Investing.com· 3 days agoThe optimism follows the U.S. Food and Drug Administration's (FDA) accelerated approval of Imdelltra...
New Clozapine Data Suggest FDA Should Ease Restrictions
Medscape· 6 days agoThe risk for severe neutropenia with clozapine is minimal, suggesting that burdensome FDA-required hematologic monitoring should be relaxed, researchers said.
Boston Scientific's modular, wireless heart rhythm implant approach clears clinical study
FierceBiotech· 15 hours agoA six-month trial showed that Boston Scientific’s pairing of modular, wireless implants for managing...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli...
Zacks via Yahoo Finance· 19 hours agoRoche Holding AG price | Roche Holding AG Quote Amgen While Wegovy and Zepbound require weekly...
Vital draw: The FDA changes guidelines for LGBTQ-plus men who want to donate blood for the first...
Santa Maria Sun· 5 days agoAn update to the Food and Drug Administration’s (FDA) guidelines on blood donation allows a whole...
Agenus sets FDA meeting for cancer therapy path By Investing.com
Investing.com· 5 days agoThe meeting will address the results of botensilimab and balstilimab (BOT/BAL) studies for patients...